The ZMPSTE24 gene helps cells process lamin A, a protein that gives the cell’s control center its shape and strength. The protein made by this gene helps your cells keep that structure stable. When both copies do not work properly, unprocessed protein can build up and may cause poor growth, tight or fragile skin, bone changes, stiff joints, and features of early aging. Pathogenic variants in the ZMPSTE24 gene are linked to rare conditions such as restrictive dermopathy and mandibuloacral dysplasia.
What is a gene?
Genes are sections of DNA that carry instructions cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, which are the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. To go into this topic in greater depth, you can find more in the LearnHub.
Overview
ZMPSTE24Gene function
What if the gene works
The ZMPSTE24 gene helps cells finish making lamin A, a protein that supports the nucleus, the cell’s control center. Its protein trims prelamin A so the nucleus keeps a stable shape.
Risk
What if the gene does not work
When the ZMPSTE24 gene does not work properly, prelamin A is not processed correctly, which can lead to a spectrum from severe restrictive dermopathy in newborns to milder progeroid conditions with growth, bone, skin, and joint changes.
Treatment
What does that mean for your treatment
Pathogenic variants in the ZMPSTE24 gene can affect treatment choices because lonafarnib is an established option for certain processing-deficient progeroid laminopathies linked to the ZMPSTE24 gene. This drug may help eligible children and adults, while other care is still tailored to each person’s symptoms and complications.
Conditions associated with ZMPSTE24
Gene function
What if the gene works
Inside many cells, the ZMPSTE24 gene handles precise protein processing at cell membranes. Its protein helps turn prelamin A into lamin A, a structural protein that supports the nucleus, the compartment that holds DNA. It also helps remove proteins that become stuck during processing in the endoplasmic reticulum, a membrane network inside cells.
One of the main jobs of the ZMPSTE24 gene is processing prelamin A into lamin A. This trimming step finishes a structural protein that helps support the nucleus.
Lamin A helps the nucleus keep its shape and stay sturdy during everyday cell activity. By enabling the final lamin A step, the ZMPSTE24 gene supports how cells organize and protect their DNA.
The ZMPSTE24 gene also helps clear proteins that get stuck while entering the endoplasmic reticulum, a membrane network that handles newly made proteins. This cleanup role supports smoother protein handling inside the cell.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal differences among people, including appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ZMPSTE24 gene can disrupt how cells trim prelamin A before it becomes lamin A, showing how ZMPSTE24 gene variants affect protein processing. Some make the protein unstable or less active, while more disruptive variants can leave little or no cutting function, causing prelamin A to build up around the nucleus. Milder variants may leave partial activity, while severe variants on both gene copies are often linked to earlier and more noticeable features of related conditions.
How variants are linked to conditions
Conditions linked to ZMPSTE24 gene variants include restrictive dermopathy and mandibuloacral dysplasia type B. When a person inherits two pathogenic variants, they can cause restrictive dermopathy, a severe condition present at birth, or mandibuloacral dysplasia type B, which may involve short stature, bone changes, tight skin, and loss of body fat. Some people also have overlapping progeroid features, and the exact pattern varies by variant.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ZMPSTE24-related conditions, risk is mainly set by the gene changes inherited in a family, not by lifestyle. A child’s chance is higher when both parents carry a harmful ZMPSTE24 variant. There is not enough evidence that diet, exercise, or other day-to-day habits lower this genetic risk.
Inheritance of ZMPSTE24 variants
For families looking into ZMPSTE24 gene inheritance, the usual pattern is autosomal recessive. This means a child inherits one ZMPSTE24 variant from each parent, and both parents are often healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of the child having the condition, a 50% chance of the child being a carrier, and a 25% chance of inheriting neither variant. Because the ZMPSTE24 gene is on chromosome 1, this pattern is the same for boys and girls.
What does my ZMPSTE24 result mean for my family?
For families with a disease-causing change in the ZMPSTE24 gene, the pattern is usually recessive, which means close relatives may be healthy carriers without knowing it. Brothers and sisters could also be carriers or, less often, have the condition if they inherited changed copies from both parents. Family implications can differ a little depending on the exact ZMPSTE24-related condition and the test result.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the ZMPSTE24 gene, doctors use genetic testing for ZMPSTE24 variants, usually on a blood sample or saliva. A lab reads the gene’s DNA code and checks for variants that may help confirm a diagnosis or show whether someone is a carrier.
When should I consider getting a genetic test?
Consider ZMPSTE24 genetic testing if a child has a rare condition with very tight skin at birth, severe growth problems, stiff joints, or features of early aging, or if these conditions run in the family. Testing can help confirm the cause and clarify whether relatives may also carry the gene change.
A genetic result is only one part of your health story
A genetic finding can provide meaningful insight, but how much it explains depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Differences in how the body breaks down, moves, or responds to a drug are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect a person’s response to medicines. It focuses on links between genes and medications to clarify why the same treatment can work differently in different people. For many drugs, genes influence both how strongly a medicine works and how the body processes it. This information can support treatment choices that are more informed and more individualized. To explore this topic in greater detail, more information is available in the LearnHub.
Drugs influenced by the ZMPSTE24 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about treatment, side effects, or new symptoms are best discussed with your doctor or pharmacist.
History
The ZMPSTE24 gene entered medical genetics through basic cell biology, after scientists recognized it as the human counterpart of a yeast gene called STE24. Early work showed that it was important for processing lamin A, a structural protein that helps support the cell nucleus. From these first observations, research expanded steadily. In the early 2000s, pathogenic variants in the ZMPSTE24 gene were linked to rare conditions with features of rapid aging and tight, fragile skin at birth, including restrictive dermopathy. These discoveries helped connect changes seen under the microscope with inherited disease in people. Over time, the ZMPSTE24 gene became an important example of how studying rare conditions can reveal broader lessons about human aging and cell structure.